Arbutus Biopharma Corporation Reports Earnings Results for the First Quarter Ended March 31, 2026

Published: 2026-05-13 10:21:26 ET ABUS

Published on 05/13/2026 at 10:21 am EDT

Arbutus Biopharma Corporation reported earnings results for the first quarter ended March 31, 2026. For the first quarter, the company reported revenue was USD 179.13 million compared to USD 1.76 million a year ago. Net income was USD 169.7 million compared to net loss of USD 24.53 million a year ago.

Basic earnings per share from continuing operations was USD 0.88 compared to basic loss per share from continuing operations of USD 0.13 a year ago. Diluted earnings per share from continuing operations was USD 0.87 compared to diluted loss per share from continuing operations of USD 0.13 a year ago.